Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Sinar Eka Selaras Tbk. (ERAL) vs Indofarma Tbk. (INAF)

Sinar Eka Selaras Tbk.Trading
Indofarma Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Sinar Eka Selaras Tbk. dan Indofarma Tbk.: Sinar Eka Selaras Tbk. diperdagangkan di Rp320 (kapitalisasi pasar 1,67 T, volume 24 jam 6,96 jt), sedangkan Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M). Perbedaan utamanya: Sinar Eka Selaras Tbk. jauh lebih besar — sekitar 4,3× kapitalisasi pasar Indofarma Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

ERALINAF
Kapitalisasi Pasar
1,67 T390,51 M
Volume
6,96 jt
Lot
69,56 rb
Perputaran
2,22 M
Harga Rata-rata
319,06
Nilai Transaksi
2,22 M
Harga Ekuilibrium Indikatif
320
Volume Ekuilibrium Indikatif
1,31 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

ERAL
Lihat detail
INAF
Lihat detail

Tentang Sinar Eka Selaras Tbk.

PT Sinar Eka Selaras Tbk (the “Company”) was established in Indonesia based on Notarial Deed No. 12 of Myra Yuwono, S.H., dated March 13, 2009. PT Erajaya Swasembada Tbk, an entity incorporated in Indonesia, is the parent company of the Company. PT Eralink International, an entity incorporated inIndonesia, is the ultimate parent of the Company.

Selengkapnya di halaman ERAL

Tentang Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Selengkapnya di halaman INAF